Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Jacob A. Udell, Mark C. Petrie, W. Schuyler Jones, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 23, pp. 2233-2246
Open Access | Times Cited: 17

Showing 17 citing articles:

Where Are We With Treatment and Prevention of Heart Failure in Patients Post–Myocardial Infarction?
Jaclyn Carberry, Guillaume Marquis‐Gravel, Eileen O’Meara, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 7, pp. 1157-1165
Open Access | Times Cited: 11
Prognosis following acute myocardial infarction
Iain Squire, Shirley Sze
European Heart Journal (2025)
Closed Access | Times Cited: 1
Sodium-Glucose Cotransporter 2 inhibitor Empagliflozin Enhances Autophagy and Reverses Remodeling in Hearts with Large, Old Myocardial Infarctions
Susumu Endo, Hiromitsu Kanamori, Akihiro Yoshida, et al.
European Journal of Pharmacology (2025), pp. 177355-177355
Closed Access
Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes
Qing Feng, Moya Wu, Zizhao Mai
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS‐MI)
Jaclyn Carberry, Mark C. Petrie, Matthew M.Y. Lee, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 3
Effect of Compound Danshen Dripping Pills on cardiac function after acute anterior ST-segment elevation myocardial infarction: A randomized trial
Bo Deng, Si-Bo Wang, Yujie Wu, et al.
Journal of Biomedical Research (2025) Vol. 38, pp. 1-1
Open Access
Possibilities of Optimizing Drug Therapy for Myocardial Infarction: a Consensus on the Use of Type 2 Sodium-Glucose Co-Transporter Inhibitors. Conciliation Document of the Expert Group
G. P. Arutyunov, С. К. Кононов, N Novitskii, et al.
Kardiologiia (2025) Vol. 65, Iss. 3, pp. 35-47
Closed Access
Advances in cardiovascular pharmacotherapy. III. Sodium-glucose cotransport type 2 inhibitors, part 1: efficacy in heart failure and myocardial infarction
Paul S. Pagel, Dustin Hang, Julie K. Freed, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2025)
Closed Access
Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction ― A Clinical Review ―
Yuichi Saito, Yoshio Kobayashi, Kenichi Tsujita, et al.
Circulation Journal (2024)
Open Access | Times Cited: 2
Empagliflozin: primum inter pares among sodium-glucose cotransporter-2 inhibitors?
Giuseppe Biondi‐Zoccai, Giacomo Frati, Mariangela Peruzzi, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 271-275
Closed Access | Times Cited: 1
Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage
Panagiota Nikolaou, Lara S. F. Konijnenberg, Ioannis V. Kostopoulos, et al.
JACC Basic to Translational Science (2024) Vol. 10, Iss. 1, pp. 43-61
Open Access | Times Cited: 1
Sodium–glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure
Eugenia Cisneros‐Barroso, Xavier Rosselló
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1606-1607
Closed Access
Patient Selection Is the Key to EMPACTing Development of Heart Failure After Myocardial Infarction
Ajar Kochar, Raghav Gattani, Muthiah Vaduganathan
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 23, pp. 2247-2249
Closed Access
Sodium‐Glucose Cotransporter‐2 Inhibitors After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Norman Lin, Jamie Sin Ying Ho, Aloysius Sheng‐Ting Leow, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature
Silvia Prosperi, Andrea D’Amato, Aurora Labbro Francia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11458-11458
Open Access
A systematic review and meta-analysis assessing the safety and efficacy of sodium-glucose co-transporter 2 inhibitor use in hospitalized patients
Feng Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
(2024)
Open Access
Renin-angiotensin system inhibitors and non-ST-elevation myocardial infarction outcomes based on left ventricular ejection fraction
Yong Hoon Kim, Ae‐Young Her, Seung‐Woon Rha, et al.
Hellenic Journal of Cardiology (2024)
Open Access
EMPACT-MI: günstige Effekte (Re-Hospitalisierung) durch Empaglifozin bei Myokardinfarkt

Aktuelle Kardiologie (2024) Vol. 13, Iss. 05, pp. 352-354
Closed Access
Page 1

Scroll to top